CIBC Private Wealth Group
STIM icon

CIBC Private Wealth Group’s Neuronetics STIM Stock Holding History

CIBC Private Wealth Group’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$28 Hold
20
– – ﹤0.01% 3355
2025
Q3 		$55 Hold
20
– – ﹤0.01% 3009
2025
Q2 		$70 Hold
20
– – ﹤0.01% 2993
2025
Q1 		$66 Hold
20
– – ﹤0.01% 3009
2024
Q4 		$30 Buy
+20
New +$21 ﹤0.01% 2934

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIBC Private Wealth Group's STIM Position: Q4 2025 in Review

CIBC Private Wealth Group held its Neuronetics (STIM) position steady in Q4 2025 at 20 shares worth $28. The position accounts for ﹤0.01% of the portfolio, ranked #3355.

CIBC Private Wealth Group first reported a position in STIM in Q4 2024 and has held it in 5 quarters since. The position peaked at $70 in Q2 2025. 95 funds tracked by Wall St. Rank hold STIM as of Q4 2025.

  • CIBC Private Wealth Group held 20 shares of Neuronetics worth $28 as of Q4 2025.
  • CIBC Private Wealth Group left its Neuronetics share count unchanged in Q4 2025.
  • Neuronetics made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #3355 holding.
  • CIBC Private Wealth Group first reported a position in Neuronetics in Q4 2024 and has held it in 5 quarters since.
  • CIBC Private Wealth Group's Neuronetics position peaked at $70 in Q2 2025.
  • 95 funds tracked by Wall St. Rank held Neuronetics as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.